Pharmacy HOME

Dmitry Kunin, Program Director

State Board of Pharmacy 
1560 Broadway, Suite 1350
Denver, CO 80202

Phone: 303-894-7800  |  Fax: 303-894-7692  |  Email: dora_pharmacyboard@state.co.us

Board Members:

• Patricia A.Evacko, PharmD, President
  Term Expires: July 1, 2022

• Kristen Wolf, PharmD, BCSCP, Vice President
  Term Expires: July 1, 2023

• James Hansen, RPh, MBA
  Term Expires: July 1, 2023

• Jasjit Gill, Pharm.D., R.Ph
  Term Expires: July 1, 2025

• Avani Soni, Pharm.D., RPh
  Term Expires: July 1, 2025

• Casey Frank, JD, MPH
  Term Expires: July 1, 2023

• Brian C. Gonzales, MSW, LCSW, LAC
  Term Expires: July 1, 2023

Joint Stakeholder Meeting - October 15, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.

• Notice and SB21-098 
• Joint Stakeholder Meeting (recording): October 15, 2021

Rulemaking Hearing - September 30, 2021

The State Board of Pharmacy will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide feedback before the Board considers adopting new and revised rules recommended by the Board and stakeholders to provide clarity and a general cleanup of the rules; and the implementations of Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as requirement for individual credentialing); Colorado Senate Bill 21-094 (concerning the continuation of the State Board of Pharmacy, and, in connection therewith, implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice or professions regulated by the board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice).

• Notice, Draft Rules, Written Comments, SB21-011, SB21-077, SB21-094, SB21-098, SB21-122, SB21-123
• Stakeholder Meeting (recording): June 14, 2021
• Joint SB21-077 Stakeholder Meeting (recording): July 26, 2021
• Stakeholder Meeting (recording): August 19, 2021

Joint Stakeholder Meeting - July 23, 2021

The Division of Professions and Occupations held a VIRTUAL Joint Stakeholder Meeting to receive feedback on the implementation of Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders), and subsequent proposed draft rules.

• HB21-1276 Joint Stakeholder Meeting (recording): July 23, 2021
• Notice, HB21-1276, and Draft Rules 

Permanent Rulemaking Hearing - March 18, 2021

The State Board of Pharmacy will hold a VIRTUAL Permanent Rulemaking Hearing for the Board to consider adopting revisions to Rule 1.00.25 to correct language in the rule that conflicts with portions of the statute in Colorado Senate Bill (Concerning required disclosures to patients regarding formal actions based on sexual misconduct). These revisions are required by the Office of Legislative Legal Services (OLLS).

• Notice, Draft Rule, and SB20-102 
• February 11, 2021: Joint Stakeholder Meeting regarding SB20-102 Corrections (recording)

Stakeholder Meeting - December 11, 2020

New guidance from the Federal Department of Health and Human Services was published by the Office of the Assistant Secretary for Health on October 20, 2020, allowing pharmacy technicians to administer immunizations. On November 19, 2020, the State Board of Pharmacy held an Emergency Rulemaking Hearing to make revisions to Rule 19.00.00, which are now effective, allowing pharmacy technicians to administer immunizations in alignment with the recent federal guidance.  

The State Board of Pharmacy will hold a VIRTUAL Stakeholder Meeting for the Board to receive feedback on these revisions, as the Board considers permanently adopting the changes to Rule 19.00.00.

• Notice, New Rule, Federal Guidance 

Permanent Rulemaking Hearing - November 19, 2020

The State Board of Pharmacy held a virtual Permanent Rulemaking Hearing to consider adopting a new rule to implement Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment); and revisions to Rule 17.00.00, as required by the Office of Legislative Legal Services.

• Notice, New Rule, and SB20-102
• November 2, 2020: Stakeholder Meeting Recording
• September 22, 2020:  Stakeholder Meeting Recording  

Permanent Rulemaking Hearing - September 17, 2020

The State Board of Pharmacy (Board) held a VIRTUAL Permanent Rulemaking Hearing for the Board to consider adoption of the proposed new and revised State Board of Pharmacy’s rules to provide general cleanup and updates; and implement Colorado House Bill 20-1050, Colorado House Bill 20-1061, Colorado Senate Bill 20-136, and Colorado Senate Bill 20-007.

• Notice, New Rule, HB20-1050, HB20-1061, SB20-136, and SB20-007
• August 6, 2020:  Stakeholder Meeting Recording Part 1, Part 2 

Permanent Rulemaking Hearing - July 16, 2020

The State Board of Pharmacy (Board) held a VIRTUAL Permanent Rulemaking Hearing for the Board to consider permanently adopting Rule 30.00.00 (Temporary Suspension of State Board of Pharmacy Rules Related to Covid-19), as it relates to the COVID-19 pandemic and Executive Order D 2020 038. The Board must also consider repealing Rule 3.04.00 (Colorado Cancer Drug Repository Program) subsequent to the approval of Colorado Senate Bill 19-081, which repeals the statutory provisions and basis of Rule 3.04.00.

• 2021 New Legislation
  • HB21-1012 Expand Prescription Drug Monitoring Program
  • HB21-1198: Healthcare Billing Requirements for Indigent Patients
  • HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
  • HB21-1169: Prohibit Discrimination Organ Transplant Recipient
  • HB21-1232: Standardized Health Benefit Plan Colorado Option
  • HB21-1276 Prevention of Substance Use Disorders
  • HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
  • HB21-1300: Health-care Provider Liens for Injured Persons
  • HB21-1307: Prescription Insulin Pricing And Access
  • SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
  • SB21-077: Remove Lawful Presence Verification Credentialing
  • SB21-094: Sunset Continue State Board of Pharmacy
  • SB21-097: Sunset Medical Transparency Act
  • SB21-098: Sunset Prescription Drug Monitoring Program
  • SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
  • SB21-123: Expand Canadian Rx Import Program
  • SB21-271: Misdemeanor Reform
• 2020 New Legislation

Board Meeting Minutes

• September 30, 2021, Pharmacy Board Meeting Minutes
• September 16, 2021, Pharmacy Board Meeting Minutes
• July 15, 2021, Pharmacy Board Meeting Minutes

Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes

• August 20, 2020, VPAC Meeting Minutes